genetherapyreview.com

Site Map | Contact Us | Privacy
Adeno-Associated Virus | Adenovirus | Alphavirus | Herpes Simplex Virus | Lentivirus | Retrovirus | Non-Viral
Clontech | Invitrogen | Lentigen | Microbix | Stratagene
Cancer Gene Therapy | Gene Therapy | Human Gene Therapy | Journal of Gene Medicine | Molecular Therapy | Nature Medicine
Biology News Net | Google News | MSN News | Science Daily | Yahoo News
Cancer | Genetics and Autoimmune | Infectious Disease
Cancer | Infectious Disease | Genetic Disorders
Journals | Gene Therapy Books | Literature Review | Technology Analysis | Educational Material

Technical

Lentigen

Lentimax™:

 

Description:

LentiMax™ is a highly optimized HIV-based Lentiviral vector that can be engineered to express any gene or gene silencing RNA of interest. Lentigen uses LentiMax to build custom-made research-grade vectors.

lentigen vector

 

Lentigen focus on custom manufacture of lentiviral vectors, users design their vector using an online tool where one simply clicks between the tabs to insert a gene, gene silencing sequence, promoter, post-transcriptional elements, and other options. The user cuts and pastes their own sequence into the appropriate fields or selects from the examples provided. Once finished, the user clicks the "checkout" tab to finalize their order. Lentigen then constructs, manufactures, and Quality Control tests the LV prior to shipment.

lentigen production

 

Lentigen's LentiMax Production System is designed for safe and optimized production of Lentiviral vectors. LentiMax and the LentiMax Production System have been engineered with numerous safety features to increase the safety of the vector system for translation into human clinical trials. Currently, LentiMax is licensed for research use only.

 

About Us | Site Map | Privacy Policy | Contact Us | ©2008 The Gene Therapy Review.